Skip to main content
Figure 5 | Cardiovascular Diabetology

Figure 5

From: Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model

Figure 5

Treatments modified iNOS gene expression while PPARγ-mediated iNOS amplification levels were similar. (a) iNOS mRNA relative expression in pooled liver samples from analyzed groups normalized to GAPDH expression. *P < 0.05. (b) eNOS mRNA relative expression in pooled liver samples from analyzed groups normalized to GAPDH expression. Results are expressed as mean ± SEM percentage of mean values obtained from equal numbers of C57BL/6J and C3He/6J mice. *P < 0.05. (c) ChIP with a PPARγ antibody of study groups was used to amplify an iNOS promoter fragment. ChIP figures percentages indicate increments or decrements regarding C57BL/6J mice fed HFHC diet. Data of C57BL/6J mice fed chow diet was established as 100%.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840